EP3101032
Blandprótín sem felur í sér mótefni gegn HER2 og lyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.1.2015EP published:
16.1.2019EP application number:
15743738.5
EP translation filed:
15.4.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
27.1.2035Expiry date:
27.1.2027Next due date:
31.1.2027
Title:
ANTI-HER2 ANTIBODY-DRUG CONJUGATE
Timeline
Today
28.1.2015EP application
16.1.2019EP Publication
15.4.2019Translation submitted
15.5.2019Registration published
27.1.2027Expires
Owner
Name:
Daiichi Sankyo Company, LimitedAddress:
3-5-1, Nihonbashi Honcho Chuo-ku, 103-8426, Tokyo, JP
Inventor
Name:
NAITO, HiroyukiAddress:
Tokyo, JP
Name:
OGITANI, YusukeAddress:
Tokyo, JP
Name:
MASUDA, TakeshiAddress:
Tokyo, JP
Name:
NAKADA, TakashiAddress:
Tokyo, JP
Name:
YOSHIDA, MasaoAddress:
Tokyo, JP
Name:
ASHIDA, ShinjiAddress:
Tokyo, JP
Name:
MORITA, KojiAddress:
Tokyo, JP
Name:
MIYAZAKI, HidekiAddress:
Tokyo, JP
Name:
KASUYA, YujiAddress:
Tokyo, JP
Name:
HAYAKAWA, IchiroAddress:
Tokyo, JP
Name:
ABE, YukiAddress:
Tokyo, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2014017777Date:
31.1.2014Country:
JP
Number:
2014168944Date:
22.8.2014Country:
JP
Number:
2014227886Date:
10.11.2014Country:
JP
Supplementary protection
SPC number:
SPC342
Classification
Categories:
C07K 16/28, A61K 31/4745, A61K 39/395, A61P 35/00, C07D 491/052
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 25.2.2019
Expires: 27.1.2020
Payer: Árnason Faktor
Number: 6
Paid: 10.12.2019
Expires: 27.1.2021
Payer: Árnason Faktor
Number: 7
Paid: 15.12.2020
Expires: 27.1.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 7.12.2021
Expires: 27.1.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.12.2022
Expires: 27.1.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.12.2023
Expires: 27.1.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.12.2024
Expires: 27.1.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.1.2026
Expires: 27.1.2027
Payer: Árnason Faktor ehf.